Aeon Biopharma earnings were -$60.1M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest AEON earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$11.8M, down 68.2% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, AEON reported annual earnings of -$39.2M, with -193.4% growth.
Aeon Biopharma (NYSEMKT: AEON) reported Q1 2026 earnings per share (EPS) of -$0.29, up 112.72% year over year. Total AEON earnings for the quarter were -$11.79 million. In the same quarter last year, Aeon Biopharma's earnings per share (EPS) was $2.28.
As of the last Aeon Biopharma earnings report, Aeon Biopharma is currently losing money. Aeon Biopharma's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$60.11 million, a 135.54% decrease year over year.
What was AEON's earnings growth in the past year?
As of Aeon Biopharma's earnings date in Q3 2026, Aeon Biopharma's earnings has grown year over year. AEON earnings in the past year totalled -$60.11 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.